Bayesian Capital Management, LP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$381,000
+162.8%
41,100
+151.3%
0.09%
+131.6%
Q4 2020$145,000
-92.7%
16,354
-90.4%
0.04%
-92.2%
Q3 2020$1,986,000
+425.4%
171,200
+237.0%
0.48%
+491.5%
Q1 2020$378,000
+285.7%
50,799
+379.2%
0.08%
+39.0%
Q2 2016$98,00010,6000.06%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Defender Capital, LLC. 581,100$2,324,0002.21%
Round Table Services, LLC 339,391$1,358,0000.52%
ARK Investment Management 1,885,641$7,543,0000.31%
WASATCH ADVISORS LP 5,337,930$21,352,0000.28%
Cedar Brook Financial Partners, LLC 41,500$166,0000.10%
Unified Trust Company, N.A. 13,716$54,0000.05%
Virtus ETF Advisers LLC 60,398$242,0000.04%
OXFORD ASSET MANAGEMENT LLP 394,703$1,579,0000.04%
FOX RUN MANAGEMENT, L.L.C. 14,465$58,0000.03%
BREWIN DOLPHIN LTD 59,123$236,4920.03%
View complete list of INOVIO PHARMACEUTICALS INC shareholders